The best evidence for progressive myoclonic epilepsy: A pathway to precision therapyAlessandro Orsini, Pasquale Striano, Roberto Michelucci et al.|Seizure|2019Cited by 87
Molecular cytogenetic characterization of an interstitial deletion of chromosome 21 (21q22.13q22.3) in a patient with dysmorphic features, intellectual disability and severe generalized epilepsyAngelo Valetto, Giuseppe Saggese, Benedetta Toschi et al.|European Journal of Medical Genetics|2012Cited by 68
Maternally derived 15q11.2‐q13.1 duplication in a child with Lennox–Gastaut‐type epilepsy and dysmorphic features: Clinical‐genetic characterization of the family and review of the literatureAlice Bonuccelli, Veronica Bertini, Angelo Valetto et al.|American Journal of Medical Genetics Part A|2016Cited by 39
A 6.5 mb deletion at 3q24q25.2 narrows Wisconsin syndrome critical region to a 750 kb interval: A potential role for <i>MBNLI</i>Veronica Bertini, Angelo Valetto, Alessandro Orsini et al.|American Journal of Medical Genetics Part A|2016Cited by 34
Expanding Phenotype of Poirier–Bienvenu Syndrome: New Evidence from an Italian Multicentrical Cohort of PatientsAlessandro Orsini, Duccio Maria Cordelli, Andrea Santangelo et al.|Genes|2022Cited by 18